Evidence map›Paper›PMID 36983890›Full record

ArticleLife (Basel, Switzerland)2023

Determination of Antioxidant, Anti-Alzheimer, Antidiabetic, Antiglaucoma and Antimicrobial Effects of Zivzik Pomegranate (

Hasan Karagecili, Ebubekir İzol, Ekrem Kirecci, İlhami Gulcin

Open access · goldAbstract read
In one paragraph

Article in Life (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
18.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 114 citations in OpenAlex.

  1. Enzyme Inhibition by Bioactive Compounds from Olive (Molecules (Basel, Switzerland) · 2026
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Metabolite Profiling of Lavender (Pharmaceuticals (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Secondary Metabolite Profiling ofLife (Basel, Switzerland) · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Antioxidants: a comprehensive review.Archives of toxicology · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Hasan KarageciliDepartment of Nursing, Faculty of Health Sciences, Siirt University, 56100 Siirt, Turkey.ORCID 0000-0001-6912-3998
Ebubekir İzolBee and Natural Products R & D and P & D Application and Research Center, Bingöl University, 12000 Bingol, Turkey.ORCID 0000-0003-0788-4999
Ekrem KirecciDepartment of Basic Medical Sciences, Faculty of Medicine, Microbiology, Kahramanmaraş Sütçü İmam University, 46050 Kahramanmaras, Turkey.
İlhami GulcinDepartment of Chemistry, Faculty of Science, Ataturk University, 25240 Erzurum, Turkey.ORCID 0000-0001-5993-1668
Atatürk University · TRBingöl University · TRKahramanmaraş Sütçü İmam University · TRSiirt Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zivzik pomegranate (

Indexed as

acetylcholinesteraseantioxidantcarbonic anhydraseenzyme inhibitionLC-MS/MS analysisPunica granatumZivzik pomegranateα-glycosidase

Identifiers

PMID36983890
PMCPMC10058309
OpenAlexW4323663380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.